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Background: Metabotropic glutamate receptors (mGluRs) are class C G protein coupled receptors with widespread
central nervous system expression. mGluR7 is a member of this family that has been implicated in numerous
physiological and pathological processes, but the very low potency of mGluR7 for glutamate, its natural ligand, raise
questions about the nature of its physiological role.
Results: Here, evidence is presented using heterologous expression in sympathetic neurons from the rat superior
cervical ganglion (SCG) and modulation of the native SCG calcium currents as an assay for receptor signaling, that
mGluR7 exhibits constitutive activity. This activity is detectable as basal calcium channel modulation in the absence
of ligand that is not observed in untransfected cells or those transfected with other members of the mGluR family.
Further, this basal channel modulation was reversibly inhibited with the mGluR7 inverse agonist MMPIP. Surprisingly,
MMPIP did not strongly inhibit agonist-induced mGluR7 activation. Finally, the selective mGluR8 agonist (R,S)-PPG was
also able to act as an inverse agonist at mGluR7.
Conclusions: These findings introduce a novel potential physiological role for mGluR7 in the nervous system,
that of a constitutively active receptor, and thereby suggest a model in which mGluR7 signaling may be impactful
without the need to invoke strong receptor activation by millimolar concentrations of extracellular glutamate.
Constitutive activity of mGluR7 may be eliminated or reduced by the presence of other group III mGluRs, perhaps
due to heterodimer formation. In addition, both MMPIP and PPG acted as inverse agonists at mGluR7, and agonists
at mGluR8.
Keywords: Metabotropic glutamate receptor, Calcium channel, Sympathetic neuronBackground
Metabotropic glutamate receptors (mGluRs) are class C
G protein coupled receptors with widespread expression
in the mammalian nervous system [1]. As such, mGluRs
are involved in many neural processes regulating im-
portant physiological and pathological processes. Com-
pared with many G protein coupled receptor subtypes,
mGluRs have relatively low affinity/potency for their na-
tive ligand, glutamate [2]. Most mGluRs exhibit KD or
EC50 values from the low to mid micromolar range [3].
This is likely the case because basal extracellular glu-
tamate levels in the nervous system tend to be relatively
high [4,5]. The group III mGluR, mGluR7 exhibits the
lowest potency of any mGluR, with estimates in the
hundreds of micromolar to low millimolar range, withCorrespondence: paul_kammermeier@urmc.rochester.edu
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unless otherwise stated.full activation requiring nearly 10 mM glutamate [6].
Thus, it is difficult to understand the physiological role
of a receptor that may only rarely get fully activated.
Here evidence is presented that when mGluR7 is
expressed in neurons, it shows a detectable level of con-
stitutive activity. This activity appeared to be relatively
low compared to full activation of the receptor, and was
reduced when other group III mGluRs were coex-
pressed. It was further demonstrated that mGluR7 con-
stitutive signaling can be inhibited by the selective
mGluR7 antagonist MMPIP [7], and also by the
mGluR8 selective agonist PPG [8].
Methods
SCG neuron isolation, cDNA injection, and plasmids
The neuronal isolation and injection procedures have
been previously described [9]. Briefly, SCG were dis-
sected from adult Wistar rats and incubated in Earle’sl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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MD) with 0.55 mg/ml trypsin (Worthington, Freehold,
NJ), 1.6 mg/ml Type IV collagenase (Worthington) for
1 hour at 35°C. Cells were then spun twice, transferred
to minimum essential medium (Fisher Scientific, Pitts-
burgh, PA), plated, and incubated at 37°C until cDNA
injection. cDNA injections was performed with an
Eppendorf 5247 microinjector and Injectman NI2 mi-
cromanipulator (Madison, WI) 4–6 hours following cell
isolation. Plasmids were stored at −20°C as a 1–2 μg/μl
stock solution in TE buffer (10 mM TRIS, 1 mM EDTA,
pH 8). The mGluR7, 8, and 4 clones (in pCDNA3.1+)
were obtained from cDNA.org (Missouri S&T cDNA
Resource Center, Rolla, MO). Concentrations of cDNAs
injected were as indicated in the text. All neurons were co-
injected with green fluorescent protein cDNA (0.02 μg/μl;
pEGFPC1; Clontech Laboratories, Palo Alto, CA, USA)
for identification of expressing cells. Cells were the incu-
bated overnight at 37°C and experiments are performed
the following day. All animal protocols were approved by
the University of Rochester’s Committee on Animal Re-
sources (UCAR).
Electrophysiology and data analysis
Patch-clamp recordings were made using 8250 glass (King
Precision Glass, Claremont, CA). Pipette resistances were
0.8-3 MΩ yielding uncompensated series resistances of 1–
5 MΩ. Series resistance compensation of ≥ 80% was used
in all recordings. Data was recorded using an Axopatch
1D patch-clamp amplifier from Axon (now Molecular De-
vices, Sunnyvale, CA). Voltage protocol generation and
data acquisition were performed using custom procedures
written for the Igor Pro software software package (Wave-
metrics, Lake Oswego, OR) by Stephen R. Ikeda (NIH,
NIAAA) on a MacMini Intel DuoCore computer with an
Instrutech ITC18 data acquisition board (HEKA Elektro-
nik). Currents were sampled at 100 kHz low-pass filtered
at 5 kHz, digitized, and stored on the computer for later
analysis. All patch-clamp experiments were performed at
21–24°C (room temperature). Data analysis was performed
using Igor Pro software (WaveMetrics, Lake Oswego, OR).
The external (bath) calcium current recording solution
contained (in mM):145 tetraethylammonium (TEA) metha-
nesulfonate (MS),10 4-(2-Hydroxyethyl)-1-piperazineetha-
nesulfonic acid (HEPES), 15 glucose, 10 CaCl2, and 300
nM tetrodotoxin, pH 7.4, osmolality 320 mOsm/kg. The
internal (pipette) solution contained: 120 N-methyl-Dglu-
camine (NMG) MS, 20 TEA, 11 EGTA, 10 HEPES, 10
sucrose, 1 CaCl2, 4 MgATP, 0.3 Na2GTP, and 14 tris-
creatine phosphate, pH 7.2, osmolality 300 mOsm/kg.
L-AP4, 6-(4-Methoxyphenyl)-5-methyl-3-(4-pyridinyl)-
isoxazolo[4,5-c]pyridin-4(5H)-one hydrochloride (MMPIP),
and (RS)-4-Phosphonophenylglycine (PPG) were obtained
from Tocris Bioscience (R&D Systems, Bristol, UK).Results
Modulation of SCG calcium currents by mGluR7
To examine its signaling, mGluR7 cDNA was injected into
nuclei of isolated SCG neurons from the adult rat along
with EGFP to identify successfully injected cells [9]. The
following day, whole-cell patch-clamp recordings were
made in expressing cells under conditions designed to iso-
late currents through the native, mostly N-type [10],
calcium channels. Because mGluR7 couples to the Gi/o
family [3], calcium current was expected to be robust and
mediated by Gβγ subunits upon receptor activation. In-
deed, application of the group III mGluR selective agonist
L-AP4 (which activates mGluR4, 6, 7, & 8 [3]) produced a
strong, reversible inhibition of the SCG calcium cur-
rents (Figure 1). Sample control and 1 mM L-AP4
inhibited current traces obtained during a 25 msec test
pulse to +10 mV are shown in the inset of Figure 1A. As
illustrated by the example cell shown in Figure 1A as
well as the average L-AP4 dose–response curve in
Figure 1B (squares), mGluR7 responded with relatively
low potency to this agonist, exhibiting an apparent IC50
of about 170 μM. This is about 10 fold lower potency
than that observed with other group III mGluRs [3]. Ac-
tivation of mGluR7 by glutamate, the natural ligand also
requires considerably more agonist than other mGluRs
[3], suggesting that mGluR7 is a low potency receptor in
general. It should be noted that the response did not
reach saturation even at 2 mM L-AP4. However at
higher concentrations, L-AP4 was not soluble. The re-
sponse of uninjected SCG neurons to 1 mM L-AP4 is
also shown in Figure 1B (open diamond, those cells
were inhibited 0 ± 0.4%, n = 5). These cells showed no
detectable response to L-AP4, indicating that the re-
sponses observed were due to heterologously expressed
mGluR7.
mGluR7 exhibits constitutive activity
The mechanism of calcium current inhibition in rat SCG
neurons by Gi/o coupled receptors, such as mGluR7, is via
direct interaction of active Gβγ with the channel’s pore
forming subunit [11-13]. Bean first characterized this
modulation by proposing a model in which uninhibited
channels gate in a “willing” mode that allows channel
opening at moderate voltages [14]. Inhibition causes the
channels to enter a “reluctant” gating mode that requires
stronger depolarization to open the channels. These mech-
anistic features give rise to a few unique characteristics.
The first is the appearance of a slow activation phase at
moderate membrane potentials evident in the sample
current trace in Figure 1 (inset). The second is a temporary
relief of inhibition following strong depolarizations. Both of
these features are diagnostic hallmarks of Gβγ-mediated
calcium channel inhibition, and both are thought to result















































Figure 1 mGluR7 expression in rat SCG neurons. A, Time course of calcium current amplitude during a test pulse to +10 mV (measured at
10 msec after the start of the step) in a rat SCG neuron expressing mGluR7. Application of 30 μM, 300 μM, and 1 mM L-AP4 at the indicated
times produced a rapid and reversible inhibition of the current. Sample control (☆) and inhibited (★) current traces are shown in the inset. B,
Average responses (±SEM) to a range of [L-AP4] from neurons expressing mGluR7 (■), and to 1 mM L-AP4 in control, uninjected cells (♢). Solid
line represents a fit to the Hill equation, revealing an IC50 value of approximately 170 μM.
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modulation of each member of the CaV2.x family has been
shown to occur through this pathway [16,17].
By employing a triple-pulse voltage protocol [18]



















































Figure 2 Calcium current basal facilitation is elevated in SCG neurons
cell (upper) and an mGluR7 expressing cell (lower) obtained using the triple
obtained in the absence of any receptor agonist. Note that the post/pre ra
higher basal facilitation levels in those cells. B, Average (± SEM) basal facilit
from SCG neurons expressing mGluR4 (°), mGluR7 (□), mGluR4 and 7 toget
other mGluRs recorded on separate days from the cells in the other group
L-AP4 concentration-response curve from mGluR7 expressing SCG neurons
to the Hill equation, with baseline fixed at 1.5. Fits to free parameters are acan be monitored in real time. This protocol consists of
two 25 msec test pulses to +10 mV. The first (the pre-
pulse, or “pre” in Figure 2A) precedes a 45 msec condi-
tioning pulse to +80 mV, and the other (the postpulse,
























  base =1.5 ± 0
  max  =2.7343 ± 0.266
  rate   =0.7579 ± 0.273
  xhalf  =176.48 ± 146
expressing mGluR7. A. Sample calcium current traces from a control
-pulse voltage protocol (shown in center). Each current trace was
tio is elevated in the mGluR7 expressing SCG neuron, reflecting the
ation, and values from individual cells, illustrating the facilitation values
her (♢), and in control SCG neurons (✕); uninjected and expressing
s). Total number of cells in each group is shown in parentheses. C,
expressed as facilitation (post/pre) values. Solid line represents a fit
s indicated (inset).
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transiently relieve Gβγ inhibition, the facilitation ratio
(post/pre) provides a real time measure of the degree to
which this pathway is active. This approach has the added
advantage of allowing an objective measure of the Gβγ
pathway even in the absence of receptor agonists. For ex-
ample, higher levels of constitutive receptor activity will
produce more free Gβγ, which produces a greater inhib-
ition and thus a higher facilitation ratio.
Interestingly, SCG neurons made to express mGluR7 ex-
hibited a significantly higher basal facilitation ratio (prior to
application of any agonist) than neurons expressing mGluR4
and recorded on the same days (Figure 2A, B). Cells ex-
pressing mGluR7 had a basal facilitation ratio of 1.48 ± 0.04
(n = 21), compared with 1.19 ± 0.03 (n = 7) cells expressing
mGluR4, and recorded on the same days. These data sug-
gest that mGluR7 exhibits some degree of constitutive sig-
naling in the absence of agonist which results in a higher
than average amount of free Gβγ.
The basal facilitation value of the mGluR4 expressing
cells was indistinguishable from a larger group of control
cells obtained on separate days (within one week of the
data described above), including uninjected cells and those
expressing mGluR2, mGluR4 or both receptors together.
The pooled results from these cells are shown in Figure 2A
and B, labeled “Control.” The average basal facilitation of
these control neurons was 1.14 ± 0.04 (n = 35). Interest-
ingly, when mGluR7 and 4 were co-expressed in the same
neurons, the basal facilitation resembled control cells at
1.17 ± 0.02 (n = 7), suggesting that constitutive signaling of
mGluR7 is inhibited by the presence of mGluR4, although
the mechanism of this phenomenon is not known.
Next, the degree to which mGluR7 signaled constitutively
was investigated. While basal facilitation was elevated in
mGluR7 expressing cells, the facilitation ratio in these neu-
rons was not high compared with that seen in cells over-
expressing Gβγ [11,19], or in the presence of saturating
concentrations of agonists of Gi/o coupled receptors [20].
Indeed, when the facilitation ratio that resulted from appli-
cation of various concentrations of L-AP4 was plotted, it
can be seen that this value could be increased to over 2.5
by even the somewhat sub-saturating concentrations of
300 μM - 2 mM L-AP4 (Figure 2C). Thus, it can be con-
cluded that while mGluR7 does appear to signal constitu-
tively, the degree of activation is relatively subtle compared
with full activation of the receptor.
Inhibition of mGluR7 constitutive activity with an inverse
agonist
If the elevated basal facilitation observed in mGluR7 ex-
pressing sympathetic neurons was in fact due to elevated
mGluR7 signaling in the absence of agonist, then the fa-
cilitation should be reduced and current should be slightly
enhanced upon application of an antagonist with inverseagonist properties. To test this prediction, the mGluR7
selective antagonist 6-(4-Methoxyphenyl)-5-methyl-3-(4-
pyridinyl)-isoxazolo[4,5-c]pyridin-4(5H)-one hydrochlor-
ide (MMPIP) was used [7]. As shown in the sample cell in
Figure 3A, application of 100 nM MMPIP to an mGluR7
expressing SCG neuron did in fact both transiently en-
hance the basal current level and reduce facilitation, con-
sistent with a reduction in constitutive signaling of the
receptors in that cell. Sample current traces (right) show
control and L-AP4 inhibited currents using the triple
pulse voltage protocol described above (upper) and
control and MMPIP enhanced current traces (lower) from
the same cell. Note that while MMPIP enhanced the
current in the prepulse, it did not detectably alter the
postpulse current, thereby resulting in a smaller post/pre
ratio. Figure 3B (left) shows post/pre ratio values for all of
the mGluR7 expressing cells in which 100 nM MPPIP was
applied. In these cells, MMPIP significantly reduced the
facilitation ratio from 1.34 ± 0.04 to 1.21 ± 0.02 (n = 9).
The absolute magnitude of the prepulse current was also
enhanced in these cells from −1.11 ± .22 nA to −1.22 ±
0.25 nA. By contrast, when 100 nM MMPIP was applied
to control, uninjected SCG neurons, the current ampli-
tude was not significantly enhanced and the facilitation
ratio was not significantly reduced. Current amplitude
of control cells was −1.06 ± .1 nA in control and −1.01
± .11 nA in MMPIP. The facilitation ratio was 1.39 ±
0.05 and 1.42 ± 0.05 in control and MMPIP, respectively
(n = 4), suggesting that the effects of MMPIP were due
to the expression of mGluR7.
Interestingly, while MMPIP appeared to effectively re-
duce constitutive mGluR7 activity, the same concentration
of MMPIP did not effectively inhibit L-AP4 activation of
the receptor in the 100 μM - 1 mM range (Figure 3B,
right). In SCG neurons expressing mGluR7, 100 μM and
1 mM L-AP4 were applied and washed off to obtain con-
trol agonist responses (Figure 3B, right, solid squares) In
the same cells, 100 μM, 300 μM, and 1 mM L-AP4 were
applied in the presence of 100 nM MMPIP (Figure 3B,
right, open squares). Responses in the presence of MMPIP
were not significantly reduced compared to control re-
sponses. This result was in contrast with those reported
by Suzuki et al. [7], in which 100 nMMMPIP was effective
as both an inverse agonist and in inhibiting L-AP4
responses. The reason for this discrepancy is unclear, but
in this study the human mGluR7 clone was transiently
expressed in rat SCG neurons, while in that study, rat
mGluR7 was stably expressed in Chinese Hamster Ovary
(CHO) cells. It is possible that affinity of MMPIP for hu-
man mGluR7 is slightly lower than for the rat sequence.
Unfortunately, application of higher concentrations of
MMPIP in the SCG calcium current assay was problem-
atic due to solubility issues and direct effects of the solvent













































































































Figure 3 mGluR7 is a constitutively active receptor. A, Time course of calcium current amplitudes (upper left) and facilitation ratios (lower left) from the
“pre” and “post” test pulses obtained with the triple pulse protocol in a representative SCG neuron during application of the indicated concentrations of
L-AP4 and 100 nM MMPIP. Sample current traces from the same cell are shown to the right. Control and L-AP4 inhibited currents are shown (upper right), as
are control and MMPIP enhanced currents (lower right). B, Plot of control facilitation values and those in the presence of MMPIP (left) in mGluR7 expressing
neurons, paired from each cell. * indicates significant difference (p < 0.05, paired T-test). L-AP4 concentration-response curve is also shown for two [L-AP4]s
when applied alone (■), and three [L-AP4]s when applied in the presence of 100 nM MMPIP (□). No significant differences were detected. C, Plot of control
facilitation values and those in the presence of PPG (left) in mGluR7 expressing neurons, paired from each cell. *indicates significant difference (p < 0.05, paired
T-test). Average responses (±SEM) to L-AP4 (black bars), MMPIP (white bars), and PPG (striped bars) in SCG neurons expressing mGluR7, mGluR8, and
mGluR7&8 together, as indicated.
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Fortuitously, the mGluR8 selective agonist (RS)-4-Phos-
phonophenylglycine (PPG) [8] was also applied to SCGneurons expressing mGluR7. Similar to the effect of
MMPIP, 1 μM PPG also significantly reduced the facili-
tation ratio in mGluR7 expressing cells, suggesting that
Kammermeier BMC Neuroscience  (2015) 16:17 Page 6 of 7it may also act as an inverse agonist at these receptors
(Figure 3C, left). In mGluR7 expressing SCG neurons,
application of 1 μM PPG reduced the facilitation ratio
from 1.35 ± 0.06 to 1.27 ± 0.04 (n = 6). As a positive con-
trol, PPG was also applied to SCG neurons expressing
mGluR8 (Figure 3C, right). In these cells, the group III
mGluR agonist L-AP4 (1 mM) produced a 20 ± 2% in-
hibition of the calcium current (n = 3). The current was
inhibited similarly, 27 ± 7%, by 1 μM PPG in the same
cells, confirming the agonistic activity of PPG. Interest-
ingly, in the same cells, application of 100 nM MMPIP
also appeared to function as an agonist, as it induced a
reversible inhibition of the calcium current of 32 ± 6%.
Thus despite their structural dissimilarity, both MMPIP
and PPG appear to act as inverse agonists at mGluR7
and agonists at mGluR8, two receptors with relatively
high homology.
Finally, 1 mM L-AP4, 100 nM MMPIP, and 1 μM PPG
were applied to SCG neurons co-expressing both
mGluR7 and mGluR8 (Figure 3C, right). It should first
be noted that these neurons did not exhibit elevated
basal facilitation as the cells expressing mGluR7 alone
did. The facilitation ratio in mGluR7/8 expressing neu-
rons was 1.25 ± 0.02 (n = 5), consistent with the observa-
tion (Figure 2, above) that co-expression of mGluR4
with mGluR7 eliminated constitutive activity. However,
in the mGluR7/8 expressing neurons, both MMPIP and
PPG had effects similar to those in cells expressing
mGluR7 alone. That is, each slightly enhanced the
current amplitude by 9 ± 4% (Figure 3C, right; n = 4),
suggesting that while the basal facilitation ratio was not
strongly elevated, some constitutive signaling may have
been occurring. Indeed, the facilitation ratio was reduced
in these cells from 1.25 ± 0.02 to 1.16 ± 0.04 by 100 nM
MMPIP and from 1.27 ± 0.03 to 1.19 ± 0.03 by 1 μM
PPG. Together, these data indicate that the mGluR8 se-
lective agonist PPG may act as an inverse agonist on
mGluR7, and that the mGluR7 inverse agonist can act as
an agonist at mGluR8.
Discussion
In the current study, the signaling properties of mGluR7
were examined adult rat sympathetic neurons from the
SCG. Group III mGluRs like mGluR7 couple to Gi/o pro-
teins, which mediate a strong, reversible inhibition of CaV2
channels [15,16] mediated by Gβγ [11,12]. Because Gβγ-
mediated calcium current inhibition exhibits a characteris-
tic voltage dependence [14,21], assessment of active G
protein levels in the presence and absence of receptor lig-
and is possible using a simple ‘triple-pulse’ voltage proto-
col [18]. Using this strategy, it was shown that SCG
neurons expressing mGluR7 by intranuclear cDNA injec-
tion exhibited significantly higher than normal levels of
free, active Gβγ, suggesting that expressed mGluR7 maybe constitutively signaling. Similar results were not ob-
served in control, uninjected neurons, nor in neurons ex-
pressing other mGluR subtypes. Thus suggests that the
elevated levels of apparent mGluR7 activation were not
likely due to elevated levels of glutamate in the extracellu-
lar environment, as the potency of mGluR7 for glutamate
is considerably lower than every other mGluR subtype [3].
The degree of constitutive activation of mGluR7 was lim-
ited however, since application of the agonist L-AP4 con-
sistently further activated the receptor, and produced a
greater level of calcium current inhibition than was ob-
served in the absence of ligand.
The suggestion that mGluR7 signals constitutively was
confirmed by application of the mGluR7 inverse agonist
MMPIP, which consistently increased current amplitudes
in mGluR7 expressing cells, but not in uninjected cells.
Further, MMPIP significantly reduced the current facili-
tation ratio, an independent measure of the degree of
active Gβγ in the cells. These data suggest that the ele-
vated Gβγ levels in mGluR7 expressing SCG neurons
were the result of signaling of mGluR7 at the level of the
receptor, and not likely a secondary effect of mGluR7
over-expression.
The observation that mGluR7 can signal constitutively
has been posited previously [7], but that observation
came only from mGluR7 expressed in CHO cells pre-
treated with forskolin, a somewhat less physiological sys-
tem than the one employed here. Indeed, another study
[22] showed elevated calcium channel facilitation in
cerebellar granule neurons that was inhibited by the
mGluR7 binding protein MacMARCKS. However in that
study, untransfected neurons had similar channel facili-
tation as mGluR7 transfected cells, despite the fact that
the authors could not detect somatic mGluR7 in
untransfected cells. Therefore, the authors could neither
confirm nor refute the potential constitutive activity of
mGluR7 in those cells. Thus this is the first definitive
demonstration of constitutive mGluR7 signaling in
neurons.
In addition to the inhibition of mGluR7 constitutive
activity by the inverse agonist MMPIP, the effect of the se-
lective mGluR8 agonist PPG was also examined. Surpris-
ingly, PPG showed similar responses when applied as
MMPIP, both in inhibiting mGluR7 activity and in its
agonist activity at mGluR8, suggesting that these two rela-
tively dissimilar compounds have similar activities at both
receptors. It is likely however, that the similar responses
induced by these compounds are coincidental because
MMPIP binds at least mGluR7 at an allosteric site, while
PPG has some structural similarity to glutamate and L-
AP4, and likely functions as an orthosteric agonist at
mGluR8. MMPIP likely acts on mGluR8 as an allosteric
agonist, or possibly as an ago-PAM (an agonist and
positive modulator acting at an allosteric site), although
Kammermeier BMC Neuroscience  (2015) 16:17 Page 7 of 7there is currently no evidence for PAM activity of
MMPIP at mGluR8.
A surprising and as yet little understood phenomenon is
the abolishment or reduction of apparent mGluR7 constitu-
tive activity when other group III mGluRs were coexpressed.
Expression of mGluR4 with mGluR7 strongly reduced basal
facilitation values to control levels, and mGluR8 expression
reduced facilitation somewhat as well. One possible explan-
ation might be that mGluR7 forms heterodimers with
mGluR4 and 8, and that mGluR7 containing dimers do not
exhibit constitutive signaling. While we do not have data to
thoroughly address this claim here, there are some hints in
the pharmacological data that could lead to at least some in-
formed hypotheses. In Figure 3C, it is clear that both
MMPIP and PPG produce similar effects as when mGluR7
is expressed alone, but the reduced basal facilitation (com-
pared to mGluR7 expressing cells) suggests that at least
some mGluR8 is expressed. One interpretation is that
mGluR7/8 heterodimers are predominantly expressed and
that these are affected by MMPIP and PPG similarly to
mGluR7 homodimers. However, since MMPIP is an allo-
steric compound and PPG likely acts at the orthosteric site,
this explanation may be unlikely. Perhaps the more likely
scenario is that under these conditions, a small number of
mGluR7/8 heterodimers are expressed with a reduced (com-
pared with cells expressing mGluR7 alone) number of
mGluR7 homodimers. This would explain the reduced fa-
cilitation values, the enhancement of current by both drugs,
and the lack of a clear agonist effect of the drugs as well.
The mechanism of the reduced facilitation ratio when
mGluR4 was expressed with mGluR7 also remains to be
elucidated.
Conclusions
The results of this study demonstrate that mGluR7 can
signal constitutively (in the absence of agonist) when
expressed in neurons. This constitutive signaling appears
to be reduced when mGluR7 is coexpressed with another
group III mGluR.
Ethics statement
Human subjects research was not conducted in this
study.
Abbreviations
SCG: Superior Cervical Ganglion; MMPIP: 6-(4-Methoxyphenyl)-5-methyl-
3-(4-pyridinyl)-isoxazolo[4,5-c]pyridin-4(5H)-one hydrochloride; PPG:
(RS)-4-Phosphonophenylglycine; mGluR: Metabotropic glutamate receptor.
Competing interests
The author declares that he has no competing interests.
Author contributions
PJK conducted all experiments, analyzed data, and wrote the manuscript.
Acknowledgments
Supported by NIH R01 GM101023.Received: 26 November 2014 Accepted: 11 March 2015
References
1. Pin J-P, Duvoisin R. The metabotropic glutamate receptors: structure and
functions. Neuropharmacology. 1995;34:1–26.
2. Schoepp DD. Unveiling the functions of presynaptic metabotropic glutamate
receptors in the central nervous system. J Pharmacol Exp Ther. 2001;299:12–20.
3. Conn PJ, Pin J-P: PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC
GLUTAMATE RECEPTORS. http://dxdoiorg/101146/annurevpharmtox371205
2003, 37:205–237.
4. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the
extracellular concentrations of glutamate and aspartate in rat hippocampus
during transient cerebral ischemia monitored by intracerebral microdialysis.
J Neurochem. 1984;43:1369–74.
5. Xi Z-X, Baker DA, Shen H, Carson DS, Kalivas PW. Group II metabotropic
glutamate receptors modulate extracellular glutamate in the nucleus
accumbens. J Pharmacol Exp Ther. 2002;300:162–71.
6. Corti C, Restituito S, Rimland JM, Brabet I, Corsi M, Pin J-P, et al. Cloning and
characterization of alternative mRNA forms for the rat metabotropic
glutamate receptors mGluR7 and mGluR8. Eur J Neurosci. 1998;10:3629–41.
7. Suzuki G, Tsukamoto N, Fushiki H, Kawagishi A, Nakamura M, Kurihara H,
et al. In Vitro Pharmacological Characterization of Novel Isoxazolopyridone
Derivatives as Allosteric Metabotropic Glutamate Receptor 7 Antagonists.
J Pharmacol Exp Ther. 2007;323:147–56.
8. Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, et al.
(R, S)-4-phosphonophenylglycine, a potent and selective group III
metabotropic glutamate receptor agonist, is anticonvulsive and
neuroprotective in vivo. J Pharmacol Exp Ther. 1999;289:1678–87.
9. Ikeda SR. Heterologous expression of receptors and signaling proteins in
adult mammalian sympathetic neurons by microinjection. Methods Mol
Biol. 1997;83:191–202.
10. Zhu Y, Ikeda SR. Adenosine modulates voltage-gated Ca2+ channels in
adult rat sympathetic neurons. J Neurophysiol. 1993;70:610–20.
11. Ikeda SR. Voltage-dependent modulation of N-type calcium channels by
G-protein beta gamma subunits. Nature. 1996;380:255–8.
12. Herlitze S, Garcia DE, Mackie K, Hille B, Scheuer T, Catterall WA. Modulation of
Ca2+ channels by G-protein beta gamma subunits. Nature. 1996;380:258–62.
13. De Waard M, Liu H, Walker D, Scott VE, Gurnett CA, Campbell KP. Direct
binding of G-protein betagamma complex to voltage-dependent calcium
channels. Nature. 1997;385:446–50.
14. Bean BP. Neurotransmitter inhibition of neuronal calcium currents by
changes in channel voltage dependence. Nature. 1989;340:153–6.
15. Ikeda SR, Dunlap K. Voltage-dependent modulation of N-type calcium
channels: role of G protein subunits. Adv Second Messenger
Phosphoprotein Res. 1999;33:131–51.
16. Dolphin AC. G protein modulation of voltage-gated calcium channels.
Pharmacol Rev. 2003;55:607–27.
17. Meza U, Thapliyal A, Bannister RA, Adams BA. Neurokinin 1 receptors trigger
overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels.
Mol Pharmacol. 2007;71:284–93.
18. Elmslie KS, Zhou W, Jones SW. LHRH and GTP-gamma-S modify calcium
current activation in bullfrog sympathetic neurons. Neuron. 1990;5:75–80.
19. Kammermeier PJ, Ruiz-Velasco V, Ikeda SR. A voltage-independent calcium
current inhibitory pathway activated by muscarinic agonists in rat sympathetic
neurons requires both Galpha q/11 and Gbeta gamma. J Neurosci.
2000;20:5623–9.
20. Ruiz-Velasco V, Ikeda SR. Multiple G-protein betagamma combinations produce
voltage-dependent inhibition of N-type calcium channels in rat superior
cervical ganglion neurons. J Neurosci. 2000;20:2183–91.
21. Ikeda SR. Double-pulse calcium channel current facilitation in adult rat
sympathetic neurones. J Physiol Lond. 1991;439:181–214.
22. Bertaso F, Lill Y, Airas JM, Espeut J, Blahos J, Bockaert J, et al. MacMARCKS
interacts with the metabotropic glutamate receptor type 7 and modulates G
protein-mediated constitutive inhibition of calcium channels. J Neurochem.
2006;99:288–98.
